Pay in 4 interest-free payments of $6.78 Learn more
Ships within 48 hours · Estimated delivery Oct 1 - Oct 6
(2022) 46:e14166
Trelagliptin (syr-472, zafatek), novel once-weekly treatment for type 2 diabetes, inhibits dipeptidyl peptidase-4 (dpp-4) via a non-covalent mechanism
This dual action helps normalize blood glucose with lower risk of hypoglycemia compared to some older diabetes medications, though the risk increases when combined with insulin or sulfonylureas
Share: A new study from Duke University School of Medicine is challenging long-standing views on blood sugar regulation -- and pointing to a surprising new ally in the fight against type 2 diabetes
US$ 20.36
US$ 28.92
US$ 25.87
US$ 26.22
US$ 24.98
US$ 24.27
US$ 20.85
US$ 28.55
US$ 23.51
US$ 21.05
US$ 24.53
